Balance Sheet
Cash Flow Statement
Amortizatization of IntangiblesCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in ReceivablesDepreciation & Amortization (CF)Depreciation and DepletionExchange Rate EffectFree Cash FlowGains from Investment SecuritiesLong-Term Debt RepaymentsNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesShare-based CompensationShares Issued
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Volitionrx (VNRX) Gains from Investment Securities (2019 - 2025)

Volitionrx (VNRX) has disclosed Gains from Investment Securities for 7 consecutive years, with $80381.0 as the latest value for Q3 2025.

  • For the quarter ending Q3 2025, Gains from Investment Securities rose 406.82% year-over-year to $80381.0, compared with a TTM value of $242661.0 through Sep 2025, up 34.23%, and an annual FY2024 reading of $3.4 million, up 1563.9% over the prior year.
  • Gains from Investment Securities was $80381.0 for Q3 2025 at Volitionrx, up from $55057.0 in the prior quarter.
  • Across five years, Gains from Investment Securities topped out at $180472.0 in Q4 2022 and bottomed at $102.0 in Q4 2021.
  • Average Gains from Investment Securities over 5 years is $57020.0, with a median of $46631.0 recorded in 2024.
  • The sharpest move saw Gains from Investment Securities soared 176833.33% in 2022, then crashed 78.64% in 2024.
  • Year by year, Gains from Investment Securities stood at $102.0 in 2021, then skyrocketed by 176833.33% to $180472.0 in 2022, then crashed by 31.49% to $123647.0 in 2023, then plummeted by 33.03% to $82812.0 in 2024, then decreased by 2.94% to $80381.0 in 2025.
  • Business Quant data shows Gains from Investment Securities for VNRX at $80381.0 in Q3 2025, $55057.0 in Q2 2025, and $24411.0 in Q1 2025.